Skip to Content

Novartis AG Registered Shares NVSEF

Morningstar Rating
$90.24 −3.40 (3.63%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NVSEF is trading at a 2% premium.
Price
$90.47
Fair Value
$64.16
Uncertainty
Medium
1-Star Price
$666.78
5-Star Price
$52.14
Economic Moat
Cskl
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NVSEF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$93.64
Day Range
$90.2490.24
52-Week Range
$90.24108.50
Bid/Ask
$89.85 / $97.11
Market Cap
$184.45 Bil
Volume/Avg
728 / 98,441

Key Statistics

Price/Earnings (Normalized)
13.75
Price/Sales
4.20
Dividend Yield (Trailing)
4.02%
Dividend Yield (Forward)
4.58%
Total Yield
8.76%

Company Profile

Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Sector
Healthcare
Industry
Drug Manufacturers - General
Stock Style Box
Large Core
Total Number of Employees
76,057

Competitors

Valuation

Metric
NVSEF
GSK
JNJ
Price/Earnings (Normalized)
13.7510.1813.97
Price/Book Value
4.104.595.10
Price/Sales
4.202.144.09
Price/Cash Flow
13.4310.2018.40
Price/Earnings
NVSEF
GSK
JNJ

Financial Strength

Metric
NVSEF
GSK
JNJ
Quick Ratio
0.880.590.91
Current Ratio
1.160.881.16
Interest Coverage
10.949.3018.88
Quick Ratio
NVSEF
GSK
JNJ

Profitability

Metric
NVSEF
GSK
JNJ
Return on Assets (Normalized)
12.15%10.54%13.98%
Return on Equity (Normalized)
27.10%50.48%35.02%
Return on Invested Capital (Normalized)
17.72%21.33%22.24%
Return on Assets
NVSEF
GSK
JNJ
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - General Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
LLY
Eli Lilly and CoBptcrlxglbRrrr$709.2 Bil
JNJ
Johnson & JohnsonHrvpvrqjcZtlr$351.2 Bil
MRK
Merck & Co IncPdckxxhVxhh$317.2 Bil
ABBV
AbbVie IncScwfzhwzkSvvt$291.6 Bil
AZN
AstraZeneca PLC ADRZfjszbnvvYgh$210.7 Bil
RHHBY
Roche Holding AG ADRFgbfflshjWlzwr$194.6 Bil
NVS
Novartis AG ADRXmxpfmmJrqk$189.7 Bil
PFE
Pfizer IncYmpqyvlctJhs$143.8 Bil
AMGN
Amgen IncYwnwktrmHlrlz$140.9 Bil
SNY
Sanofi SA ADRWgdkcyppHdyf$115.4 Bil

Sponsor Center